Position in AKTS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,375,450
+$5,951,100 QoQ
Shares Held
415,000
0.0% QoQ
Ownership
0.746%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#20
of 113 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AKTS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026a16z Capital Management, L.L.C. holds $351,662,456 across 9 Biotechnology names. AKTS ranks #6 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
921,099 | $172,503,420 | |
| 2 | ERAS |
Erasca, Inc.
|
2,862,500 | $52,441,000 | |
| 3 | MAZE |
Maze Therapeutics, Inc.
|
1,702,225 | $50,794,394 | |
| 4 | DMRA |
Damora Therapeutics, Inc.
|
1,236,157 | $32,152,443 | |
| 5 | NAUT |
Nautilus Biotechnology, Inc.
|
9,063,054 | $16,947,910 | |
| 6 | AKTS |
Aktis Oncology, Inc.
This page
|
415,000 | $13,375,450 | |
| 7 | CAMP |
Camp4 Therapeutics Corp
|
2,125,339 | $9,287,731 | |
| 8 | KLRA |
Kailera Therapeutics, Inc.
|
140,000 | $3,084,200 |
All Filings in AKTS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,375,450 | 415,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,424,350 | 415,000 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||